TELA Bio, Inc. (TELA): Capital Expenditures
$448.0K
Year ended 2025-12-31
$480.0K
Trailing 12 months to 2026-06-30
-19.9%
3-year compound annual growth
+21.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $448.0K | -54.7% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $989.0K | +61.9% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $611.0K | -29.9% | 2026-03-25, From 2023-01-01 |
| 2022-12-31 | $872.0K | +39.1% | 2025-03-21, From 2022-01-01 |
| 2021-12-31 | $627.0K | +275.4% | 2024-03-22, From 2021-01-01 |
| 2020-12-31 | $167.0K | -15.2% | 2023-03-23, From 2020-01-01 |
| 2019-12-31 | $197.0K | +217.7% | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $62.0K | -45.6% | 2021-03-25, From 2018-01-01 |
| 2017-12-31 | $114.0K | n/a | 2020-03-30, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| TELA Bio, Inc. (TELA) | 2025-12-31 | $448.0K | -54.7% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $483.0K | -61.2% |
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $224.0K | -41.8% |
| Iradimed Corp (IRMD) | 2025-12-31 | $7.76M | -3.0% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $1.55M | +176.7% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $1.00M | -89.0% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $452.0K | -68.8% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $34.89M | +52.1% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $332.0K | +8.5% |
Compare TELA, PDEX, SGHT, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗